Edesa Biotech Inc (EDSA)
4.44
0.00 (0.00%)
USD |
NASDAQ |
May 01, 16:00
4.44
0.00 (0.00%)
After-Hours: 20:00
Edesa Biotech Free Cash Flow: -6.252M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| December 31, 2023 | -6.252M |
| September 30, 2023 | -6.636M |
| June 30, 2023 | -10.80M |
| March 31, 2023 | -12.02M |
| December 31, 2022 | -10.86M |
| September 30, 2022 | -12.28M |
| June 30, 2022 | -7.011M |
| March 31, 2022 | -7.106M |
| December 31, 2021 | -13.87M |
| September 30, 2021 | -13.67M |
| June 30, 2021 | -14.99M |
| March 31, 2021 | -13.25M |
| December 31, 2020 | -7.243M |
| September 30, 2020 | -5.021M |
| June 30, 2020 | -4.630M |
| March 31, 2020 | -4.562M |
| December 31, 2019 | -4.384M |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | -4.861M |
| December 31, 2018 | -5.134M |
| September 30, 2018 | -4.998M |
| June 30, 2018 | -5.225M |
| March 31, 2018 | -4.973M |
| December 31, 2017 | -4.732M |
| Date | Value |
|---|---|
| September 30, 2017 | -5.002M |
| June 30, 2017 | -5.082M |
| March 31, 2017 | -5.165M |
| December 31, 2016 | -5.008M |
| September 30, 2016 | -4.908M |
| June 30, 2016 | -4.596M |
| March 31, 2016 | -4.559M |
| December 31, 2015 | -4.712M |
| September 30, 2015 | -4.687M |
| June 30, 2015 | -4.517M |
| March 31, 2015 | -4.525M |
| December 31, 2014 | -4.670M |
| August 31, 2014 | -4.546M |
| May 31, 2014 | -4.295M |
| February 28, 2014 | -3.952M |
| November 30, 2013 | -3.281M |
| August 31, 2013 | -2.805M |
| May 31, 2013 | -3.216M |
| February 28, 2013 | -3.509M |
| November 30, 2012 | -3.851M |
| August 31, 2012 | -4.026M |
| May 31, 2012 | -4.011M |
| February 29, 2012 | -3.993M |
| November 30, 2011 | -3.549M |
| August 31, 2011 | -2.928M |
Free Cash Flow Range, Past 5 Years
-14.99M
Minimum
Jun 2021
-4.384M
Maximum
Dec 2019
-9.094M
Average
-7.243M
Median
Dec 2020
Free Cash Flow Benchmarks
| Acasti Pharma Inc | -13.57M |
| Aurinia Pharmaceuticals Inc | -34.18M |
| Lexaria Bioscience Corp | -5.408M |
| Xenon Pharmaceuticals Inc | -150.94M |
| ESSA Pharma Inc | -22.19M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -1.406M |
| Cash from Financing (Quarterly) | 0.3057M |
| Free Cash Flow Per Share (Quarterly) | -0.4497 |
| Free Cash Flow Yield | -46.99% |